186 related articles for article (PubMed ID: 33793366)
41. Current progress in perioperative chemotherapy for biliary tract cancer.
Ioka T; Shindo Y; Ueno M; Nagano H
Ann Gastroenterol Surg; 2023 Jul; 7(4):565-571. PubMed ID: 37416744
[TBL] [Abstract][Full Text] [Related]
42. Neoadjuvant and adjuvant multimodality therapies in resectable esophagogastric adenocarcinoma.
Lau DK; Athauda A; Chau I
Expert Opin Pharmacother; 2021 Aug; 22(11):1429-1441. PubMed ID: 33688789
[No Abstract] [Full Text] [Related]
43. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.
Daines WP; Rajagopalan V; Grossbard ML; Kozuch P
Oncology (Williston Park); 2004 Jul; 18(8):1049-59; discussion 1060, 1065-6, 1068. PubMed ID: 15328897
[TBL] [Abstract][Full Text] [Related]
44. Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma.
Brunner TB; Eccles CL
Strahlenther Onkol; 2010 Dec; 186(12):672-80. PubMed ID: 21136029
[TBL] [Abstract][Full Text] [Related]
45. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
Slagter AE; Jansen EPM; van Laarhoven HWM; van Sandick JW; van Grieken NCT; Sikorska K; Cats A; Muller-Timmermans P; Hulshof MCCM; Boot H; Los M; Beerepoot LV; Peters FPJ; Hospers GAP; van Etten B; Hartgrink HH; van Berge Henegouwen MI; Nieuwenhuijzen GAP; van Hillegersberg R; van der Peet DL; Grabsch HI; Verheij M
BMC Cancer; 2018 Sep; 18(1):877. PubMed ID: 30200910
[TBL] [Abstract][Full Text] [Related]
46. Guidelines for chemotherapy of biliary tract and ampullary carcinomas.
Furuse J; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Kondo S; Saito H; Tsuyuguchi T; Hirata K; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):55-62. PubMed ID: 18274844
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathological Features of Surgically-resected Biliary Tract Cancer Following Chemo-radiation Therapy.
Kobayashi S; Gotoh K; Takahashi H; Akita H; Marubashi S; Yamada T; Teshima T; Nishiyama K; Yano M; Ohigashi H; Ishikawa O; Sakon M
Anticancer Res; 2016 Jan; 36(1):335-42. PubMed ID: 26722062
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of omega-3 fatty acid administration on completion rate of adjuvant chemotherapy for biliary tract cancer: study protocol for a single-centre, open-label, single-arm, historically controlled study.
Ueno K; Ajiki T; Tsugawa D; Akita M; Hashimoto Y; Awazu M; Mukubo H; Komatsu S; Kuramitsu K; Terai S; Tanaka M; Toyama H; Kido M; Fukumoto T
BMJ Open; 2019 Aug; 9(8):e029915. PubMed ID: 31401605
[TBL] [Abstract][Full Text] [Related]
49. Emerging treatment strategies in hepatobiliary cancer.
Guven DC; Yildirim HC; Chalabiyev E; Kus F; Yilmaz F; Yasar S; Akyildiz A; Aktas BY; Yalcin S; Dizdar O
Expert Rev Anticancer Ther; 2023 Mar; 23(3):243-256. PubMed ID: 36803258
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant Therapy for Biliary Tract Cancers.
Horgan AM; Knox JJ
J Oncol Pract; 2018 Dec; 14(12):701-708. PubMed ID: 30537458
[TBL] [Abstract][Full Text] [Related]
51. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
52. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
53. [Indications for combined resection and reconstruction of the hepatic artery in biliary tract carcinoma].
Endo I; Masunari H; Sugita M; Morioka D; Tanaka K; Togo S; Sekido H; Yoshida T; Shimada H
Nihon Geka Gakkai Zasshi; 2001 Nov; 102(11):820-5. PubMed ID: 11729649
[TBL] [Abstract][Full Text] [Related]
54. Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients.
Im JH; Seong J; Lee IJ; Park JS; Yoon DS; Kim KS; Lee WJ; Park KR
Cancer Res Treat; 2016 Apr; 48(2):583-95. PubMed ID: 26323644
[TBL] [Abstract][Full Text] [Related]
55. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
Sheka AC; Altman A; Marmor S; Hui JYC; Denbo JW; Ankeny JS; Jensen EH
Surg Oncol; 2020 Sep; 34():298-303. PubMed ID: 32891346
[TBL] [Abstract][Full Text] [Related]
56. [Adjuvant arterial infusion chemotherapy for patients with biliary cancer].
Takeda Y; Hasuike Y; Kashiwazaki M; Tsujinaka T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1835-7. PubMed ID: 15553731
[TBL] [Abstract][Full Text] [Related]
57. Approach to Resectable Biliary Cancers.
Washington K; Rocha F
Curr Treat Options Oncol; 2021 Sep; 22(11):97. PubMed ID: 34524554
[TBL] [Abstract][Full Text] [Related]
58. Neoadjuvant chemotherapy for resectable non-small-cell lung cancer.
Gray J; Sommers E; Alvelo-Rivera M; Robinson L; Bepler G
Oncology (Williston Park); 2009 Sep; 23(10):879-86. PubMed ID: 19839429
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer.
Keedy VL; Berlin J
Curr Treat Options Oncol; 2006 Sep; 7(5):381-8. PubMed ID: 16904055
[TBL] [Abstract][Full Text] [Related]
60. Regional chemotherapy in biliary tract cancers--a single institution experience.
Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z
Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
